#SharpeLab - Twitter Hashtag

Gene Lay Institute of Immunology & Inflammation @GeneLayInst

10 months ago

Therapeutic blockade of STUB1 in T cells could boost anti-tumor immunity. New study from the #SharpeLab led by @MartinLaFleur18 & @LaurenMilling, published in @NatImmunol: https://t.co/eopKclygzK @GeneLayInst @harvardmed @broadinstitute https://t.co/83DbcxMtr8

0

8

2

1

903

arvie 아비, PhD @arvieabiero

over 1 year ago

That’s a wrap! What an amazing time representing the #SharpeLab @MelissaJSharpe. First @biolpsychaust conference and it did not disappoint! Learned a lot! From brilliant keynote speakers to power-packed symposiums, the energy was intense. #BPA2024 @Kiruthika_G17 @mtaira_723 🧠

arvieabiero's tweet photo. That’s a wrap! What an amazing time representing the #SharpeLab @MelissaJSharpe. First @biolpsychaust conference and it did not disappoint! Learned a lot! From brilliant keynote speakers to power-packed symposiums, the energy was intense. #BPA2024 @Kiruthika_G17 @mtaira_723 🧠 https://t.co/64z4ShVGyy

1

24

3

0

1K

Zuri 🇵🇹

@zuri_nft

about 2 years ago

Time to gear up! @SharpeLabs has revealed IDO details including a $100,000 raise and a snapshot date of April 10th. Stay tuned for more updates! #crypto #IDO #SharpeLab

AIT Protocol @AITProtocol

about 2 years ago

SharpeLabs IDO Details unveiled 🧪🔥 IDO Details: @SharpeLabs 🔹 Raise: $100,000 🔹 Price: $0,02 🔹 Vesting: 20% TGE, 2M Cliff, 8M Linear 🔹 Eligible Pool: 56 days 🔹 Snapshot Date: 10th April 🔹 IDO Date: TBA after snapshot 🔹 Allocation per Tier: TBA ❗Reminder: users who have finished the lock period need to restake to be qualified. More info: 🫳 https://t.co/gPaA0shPRQ

AITProtocol's tweet photo. SharpeLabs IDO Details unveiled 🧪🔥

IDO Details: @SharpeLabs
🔹 Raise: $100,000
🔹 Price: $0,02
🔹 Vesting: 20% TGE, 2M Cliff, 8M Linear
🔹 Eligible Pool: 56 days
🔹 Snapshot Date: 10th April
🔹 IDO Date: TBA after snapshot
🔹 Allocation per Tier: TBA

❗Reminder: users who have finished the lock period need to restake to be qualified.

More info: 🫳
https://t.co/gPaA0shPRQ

61

374

100

26

112K

6

13

3

0

2K

Sumanta K. Pal, MD, FASCO

@montypal

about 3 years ago

How can we overcome microbiome-related IO resistance? Could PD-L2 play a role? Brilliant paper from #microbiome & #immuotherapy powerhouse laboratories in @Nature (https://t.co/H52aPOy3yo) #SharpeLab @JenWargoMD